Cargando…

Fixed cell-based assays for autoantibody detection in myasthenia gravis: a diagnostic breakthrough

Detalles Bibliográficos
Autor principal:	Budhram, Adrian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432854/ https://www.ncbi.nlm.nih.gov/pubmed/37601007 http://dx.doi.org/10.1016/j.lanwpc.2023.100876

Ejemplares similares

Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics
por: Lazaridis, Konstantinos, et al.
Publicado: (2020)

Autoantibodies to Agrin in Myasthenia Gravis Patients
por: Zhang, Bin, et al.
Publicado: (2014)

Autoantibodies in Japanese patients with ocular myasthenia gravis
por: Nagaishi, Akiko, et al.
Publicado: (2020)

Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis
por: Spagni, Gregorio, et al.
Publicado: (2022)

Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture
por: Koneczny, Inga, et al.
Publicado: (2019)

Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management
por: Lazaridis, Konstantinos, et al.
Publicado: (2020)

A multicentre, prospective, double-blind study comparing the accuracy of autoantibody diagnostic assays in myasthenia gravis: the SCREAM study
por: Li, Zhiguo, et al.
Publicado: (2023)

Detection of Antibodies against the Acetylcholine Receptor in Patients with Myasthenia Gravis: A Comparison of Two Enzyme Immunoassays and a Fixed Cell-Based Assay
por: Gambino, Caterina Maria, et al.
Publicado: (2023)

Myasthenia gravis complement activity is independent of autoantibody titer and disease severity
por: Fichtner, Miriam L., et al.
Publicado: (2022)

Editorial Comment to Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer
por: Tomisaki, Ikko
Publicado: (2019)

Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)

Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011)

Myasthenia Gravis
Publicado: (1905)

Myasthenia Gravis
por: Wilson, Andrew
Publicado: (1952)

Myasthenia Gravis
por: Bramwell, Edwin
Publicado: (1901)

Heterogeneity of Acetylcholine Receptor Autoantibody–Mediated Complement Activity in Patients With Myasthenia Gravis
por: Obaid, Abeer H., et al.
Publicado: (2022)

Immunoregulatory Cells in Myasthenia Gravis
por: Wu, Ying, et al.
Publicado: (2020)

Thymectomy for myasthenia gravis
por: Moorehead, R J, et al.
Publicado: (1985)

Thymectomy in Myasthenia Gravis
por: Dunlop, D. M.
Publicado: (1953)

Thymectomy in Myasthenia Gravis
por: Brown, K. Paterson
Publicado: (1953)

Thymectomy for Myasthenia Gravis
por: Keynes, Geoffrey
Publicado: (1949)

The epidemiology of myasthenia gravis
por: Bubuioc, Ana-Maria, et al.
Publicado: (2021)

Diagnosis of Myasthenia Gravis
por: Rousseff, Rossen T.
Publicado: (2021)

Afterdischarges in Myasthenia Gravis
por: Yang, Li, et al.
Publicado: (2021)

Diagnostic yields and clinical features of ocular myasthenia gravis
por: Kim, Hyuna, et al.
Publicado: (2021)

Cytometric cell-based assays for anti-striational antibodies in myasthenia gravis with myositis and/or myocarditis
por: Kufukihara, Kenji, et al.
Publicado: (2019)

Evaluating an In-House Cell-Based Assay for Detecting Antibodies Against Muscle-Specific Tyrosine Kinase in Myasthenia Gravis
por: Kim, Min Ju, et al.
Publicado: (2021)

Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
por: Townsel, Courtney, et al.
Publicado: (2016)

Psychometric Properties of the Quantitative Myasthenia Gravis Score and the Myasthenia Gravis Composite Scale
por: Barnett, Carolina, et al.
Publicado: (2015)

Thymoma-associated anti-LGI1 encephalitis and myasthenia gravis: A unique combination with autoantibodies
por: Satake, Akane, et al.
Publicado: (2022)

Employment in refractory myasthenia gravis: A Myasthenia Gravis Foundation of America Registry analysis
por: Harris, Linda, et al.
Publicado: (2019)

Myasthenia Gravis: Analysis of Serum Autoantibody Reactivities to 1827 Potential Human Autoantigens by Protein Macroarrays
por: Becker, Anne, et al.
Publicado: (2013)

Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients
por: Kordas, Gregory, et al.
Publicado: (2014)

Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features
por: Park, Kee Hong, et al.
Publicado: (2018)

Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients
por: Takata, Kazushiro, et al.
Publicado: (2019)

Affinity maturation is required for pathogenic monovalent IgG4 autoantibody development in myasthenia gravis
por: Fichtner, Miriam L., et al.
Publicado: (2020)

Development and Application of a Cell-Based Assay for LRP4 Antibody Associated With Myasthenia Gravis
por: Chung, Hye Yoon, et al.
Publicado: (2023)

Comparison of Clinical Manifestations between Patients with Ocular Myasthenia Gravis and Generalized Myasthenia Gravis
por: Roh, Hyun Seok, et al.
Publicado: (2011)

Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy
por: Fichtner, Miriam L., et al.
Publicado: (2022)

Myasthenia Gravis: A Review
por: Jayam Trouth, Annapurni, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0p385lacspl6qsts5tn2t3vobs